Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102734 · ClinicalTrials.gov registry record
Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 44
- Enrollment target
NCT05102734: Completed study, sponsored by University of Pennsylvania.
NCT05102734 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102734 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This is an open-label, single center, trial that will enroll up to 25 participants with circulatory shock after cardiac surgery. Participants will be administered a topical sublingual nitroglycerin solution and assessed for changes microcirculatory blood flow using incident dark field microscopy.
Primary Outcome
Estimate of functional capillary density.
Interventions
- DRUG Nitroglycerin Topical Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-03-01 |
What the finished NCT05102734 record still lists
NCT05102734 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nitroglycerin Topical Product is the first listed.
NCT05102734 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102734 about?
NCT05102734 is a clinical study titled "Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.". This is an open-label, single center, trial that will enroll up to 25 participants with circulatory shock after cardiac surgery. Participants will be administered a topical sublingual nitroglycerin solution and assessed for changes microcirculatory blood flow using incident dark field microscopy.
What is the current status of trial NCT05102734?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2021-09-01. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT05102734?
The interventions under investigation include: Nitroglycerin Topical Product (DRUG).
Who is sponsoring clinical trial NCT05102734?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI